<DOC>
	<DOCNO>NCT00237588</DOCNO>
	<brief_summary>To determine angiotensin-II AT-1 receptor blockade ( ARB ) may improve insulin sensitivity assess hyperinsulinaemic isoglycaemic glucose clamp , CCB therapy comparable dose regard blood pressure-lowering effect .</brief_summary>
	<brief_title>Glucose Optimisation With Angiotensin II Antagonist Losartan ( GOAAL )</brief_title>
	<detailed_description>Patients hypertension increase prevalence insulin resistance increase risk develop diabetes mellitus age . Different antihypertensive regimen vary effect glucose metabolism development diabetes mellitus . In double-blind , randomize cross-over study aim compare metabolic effect 10 mg amlodipine 100 mg losartan + 5 mg amlodipine patient hypertension risk factor metabolic syndrome . After 4-week open label amlodipine 5 mg run-in period , hypertensive patient randomize additional treatment either amlodipine 5 mg losartan 100 mg 8 week . At end 8-week treatment-period physical examination , laboratory-tests , hyperinsulinaemic isoglycaemic glucose clamp , heart rate variability baroreflex sensitivity measurement . Following 4-week wash-out phase subject continue open label 5 mg amlodipine , cross opposite treatment regimen another 8 week final examination .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Angiotensin II</mesh_term>
	<mesh_term>Angiotensinogen</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Essential hypertension diastolic blood pressure 95110 mmHg systolic blood pressure &lt; 180 mmHg Previously untreated hypertension treat monotherapy ( ACEinhibitors Angiotensin IIreceptor blocker ) Impaired glucose tolerance impair fast glucose ( fast plasma glucose ; 6.17.0 mmol/l ( 110126 mg/dl ) Age 18 Informed consent Any one : Microalbuminuria ( urin excretion &gt; 20 microg/min ) , dyslipidemia ( HDLcholesterol &lt; 0.9 mmol/l ( 35 mg/dl ) , Triglycerides &gt; 1.7 mmol/l ( 150 mg/dl ) , waist hipratio &gt; 0.9 men &gt; 0.85 woman , BMI &gt; 28 kg/m2 . Previous current use ACEinhibitors Angiotensin IIreceptor blocker Previous current antidiabetic medication `` Brittle '' prediabetes investigator anticipate pharmacological treatment within next 6 month Hypertensive patient investigator anticipate polytherapy within next 6 month Female patient pregnant nursing planning pregnancy within duration study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2005</verification_date>
	<keyword>Angiotensin II Type I Receptor Blockers</keyword>
	<keyword>Amlodipine</keyword>
	<keyword>Calcium Channel Blockers</keyword>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Insulin Resistance</keyword>
	<keyword>Losartan</keyword>
</DOC>